What is OrthoPediatrics's D&A?

OrthoPediatrics (KIDS) reported D&A of $5.72M in Q1 2026.

How has OrthoPediatrics's D&A changed year-over-year?

OrthoPediatrics's D&A increased by 13.3% year-over-year, from $5.05M to $5.72M.

What is the long-term trend for OrthoPediatrics's D&A?

Over 4 years (2021 to 2025), OrthoPediatrics's D&A has grown at a 18.6% compound annual growth rate (CAGR), from $10.68M to $21.12M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

OrthoPediatrics KIDS D&A

D&A at other companies

Johnson & JohnsonJNJ

$2B+13.1%

Zimmer Biomet HoldingsZBH

$270M+6.1%

MedtronicMDT

$716M-14.8%

Alphatec HoldingsATEC

$19.14M-3.9%

SI-BONE, Inc.SIBN

$1.62M+26.5%

Globus MedicalGMED

$69.86M+6.4%

Other financials

Income statement

See full

Revenue$59.4M+13.3%

Gross profit$43.4M+13.4%

Operating income-$8.3M+24.1%

Net income-$10.7M-0.3%

EPS (diluted)-$0.45+2.2%

Balance sheet

See full

Cash & equivalents$14.2M-59.8%

Total debt$5.4M+271%

Total equity$338.7M-2.4%

Total assets$502.2M+6.8%

Cash flow

See full

Operating cash flow-$3.3M+20.9%

CapEx$1.8M-58.4%

Free cash flow-$5.0M+39.8%

Valuation

See full

Market cap$503.94M+0.3%

Enterprise value$495.11M+5.7%

P/S2.1×-0.3×

Profitability

See full

Gross margin73.1%+0.3pp

Operating margin-15%-1.6pp

Net margin-16.3%-2.1pp

FCF margin-12.9%-4.3pp

Returns & leverage

See full

Return on equity-11.6%+0.2pp

Debt / equity0×0.0×

Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OrthoPediatrics's D&A?: OrthoPediatrics (KIDS) reported D&A of $5.72M in Q1 2026.
How has OrthoPediatrics's D&A changed year-over-year?: OrthoPediatrics's D&A increased by 13.3% year-over-year, from $5.05M to $5.72M.
What is the long-term trend for OrthoPediatrics's D&A?: Over 4 years (2021 to 2025), OrthoPediatrics's D&A has grown at a 18.6% compound annual growth rate (CAGR), from $10.68M to $21.12M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.